Therapeutic approaches to Alzheimer's disease
Open Access
- 29 September 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Brain
- Vol. 129  (11) , 2840-2855
- https://doi.org/10.1093/brain/awl280
Abstract
Alzheimer's disease is an age-related progressive neurodegenerative disorder with an enormous unmet medical need. It is the most common form of dementia affecting âŒ5% of adults over 65 years. In view of our ageing society the number of patients, as well as the economical and social impact, is expected to grow dramatically in the future. Currently available medications appear to be able to produce moderate symptomatic benefits but not to stop disease progression. The search for novel therapeutic approaches targeting the presumed underlying pathogenic mechanisms has been a major focus of research and it is expected that novel medications with disease-modifying properties will emerge from these efforts in the future. In this review, currently available drugs as well as novel therapeutic strategies, in particular those targeting amyloid and tau pathologies, are discussed.Keywords
This publication has 79 references indexed in Scilit:
- Rivastigmine for Alzheimer's diseasePublished by Wiley ,2015
- Galantamine for Alzheimer's disease and mild cognitive impairmentCochrane Database of Systematic Reviews, 2006
- Donepezil for dementia due to Alzheimer's diseaseCochrane Database of Systematic Reviews, 2006
- Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a metaâanalysis of individual patient data from randomised controlled trialsInternational Journal of Geriatric Psychiatry, 2004
- Glutamate and the glutamate receptor system: a target for drug actionInternational Journal of Geriatric Psychiatry, 2003
- Widely Spread Butyrylcholinesterase Can Hydrolyze Acetylcholine in the Normal and Alzheimer BrainNeurobiology of Disease, 2002
- Cholesterol-Dependent Îł-Secretase Activity in Buoyant Cholesterol-Rich Membrane MicrodomainsNeurobiology of Disease, 2002
- Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairmentAnnals of Neurology, 2002
- A Cholesterol-Lowering Drug Reduces ÎČ-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's DiseaseNeurobiology of Disease, 2001
- An english translation of alzheimer's 1907 paper, âĂŒber eine eigenartige erkankung der hirnrindeâClinical Anatomy, 1995